Emerging evidence associates the expression levels of genes involved in the NER process and some types of cancer, while data on STS are limited, so we evaluated the gene expression of three key genes (ERCC1, ERCC2 and ERCC5) in the NER pathway in 24 tissue samples from the 32 patients in our cohort. The gene discussed is ERCC5; the disease is cancer.